Skip to content

The Efficacy of Speech Competition Training on Auditory Hallucination in Schizophrenia

The Efficacy of Speech Competition Training on Auditory Hallucination in Schizophrenia

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05850923
Enrollment
100
Registered
2023-05-09
Start date
2022-11-15
Completion date
2024-06-30
Last updated
2023-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Auditory Hallucination

Keywords

Schizophrenia, Intervention

Brief summary

One hundred schizophrenia patients with auditory hallucinations will be recruited and randomized into group A and group B. Participants of group A will firstly receive a speech competition training for 2 weeks, and those in group B will firstly receive music intervention as placebo treatment. Specifically, speech competition training include voice competition training twice a day in adjunction with drug treatment, and the patients will be required to perform voice-related tasks according to the instruction. The reaction time, accuracy rate and the number of auditory hallucinations during the task will be recorded. On the other hand, the placebo treatment includes soothing music twice a day for a fixed period of time while patients receiving drug treatment. After 2 weeks, the interventions for group A and group B will be switch. Clinical symptoms will be evaluated using the auditory hallucinations rating scale, positive and negative syndrome scale, belief about voices questionnaire-revised at baseline, 2-week follow up and 4-week follow up. All the data will be analyzed with the Statistical Product and Service Solutions(SPSS) software.

Interventions

OTHERspeech competition training

Speech competition training include voice competition training twice a day in adjunction with drug treatment, and the patients will be required to perform voice-related tasks according to the instruction.

OTHERthe soothing music

the soothing music

Sponsors

Jing SHI
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

At first, all the participants will be randomized into a speech competition experimental group and a placebo control group, after 2 weeks the two interventions for two arms will be switch.

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Fulfilling the diagnostic criteria for schizophrenia as in the International Classification of Diseases (ICD) - 10; * Aged 18-55 years old; * Education level over 6 years; * The score of P3 item in PANSS ≥ 3 points; * Taking antipsychotics at a therapeutic dose for at least 1 month, and the symptoms of auditory hallucinations have not been significantly improved, and the score of Auditory Hallucinations Rating Scale (AHRS) is still greater than 18 points; * Capable of understanding and singing a written informed consent form, and be able to cooperate in completing intervention training and assessments.

Exclusion criteria

* Diagnosing other Axis I mental disorders; * A history of severe neurological disease, brain trauma, major physical disease or history of drug dependence; * Auditory hallucinations caused by organic brain diseases; * Patients who cannot cooperate with the completion of training; * Patients with serious suicidal or self injurious behavior; * Pregnant and lactating women; * History of alcohol abuse; * Intellectual impairment (IQ\<70); * Patients with hearing impairment.

Design outcomes

Primary

MeasureTime frameDescription
Auditory Hallucinations Rating Scale (AHRS)Change of AHRS score from baseline at 2 weeks and 4 weeks respectivelyThe Hoffman Hallucination Rating Scale (AHRS) is a clinical tool used to assess the severity of auditory hallucinations in patients. In current study, the scale is used to evaluate the severity of auditory hallucinations in patients with schizophrenia, mainly from seven aspects: frequency, authenticity, loudness, number of sounds, duration, attention significance, and pain level.
Belief About Voices Questionnaire-Revised (BAVQ-R)Change of BAVQ-R score from baseline at 2 weeks and 4 weeks respectivelyThis scale is a self-assessment scale developed by Chadwick et al., used to measure the beliefs, emotions, and behaviors of patients with auditory hallucinations, with a total of 35 items. Straus et al. reconducted factor analysis on its basis and extracted four factors, namely victim belief (authority belief+malicious belief), goodwill belief, participation in auditory hallucinations, and resistance to auditory hallucinations. The scale items are scored using the Likert 4-level scoring method, with a score of 0-3 and independent scores for each dimension.

Secondary

MeasureTime frameDescription
Negative and Negative Syndrome Scale (PANSS)Change of PANSS score from baseline at 2 weeks and 4 weeks respectivelyThe Negative and Positive Symptoms Scale is a widely used scale for assessing patients' clinical symptoms. The PANSS scale has a total of 30 items, including three subscales of positive symptoms, negative symptoms and general psychopathological symptoms. Each item is scored 1-7 in increasing order of severity. The sum of the items contained in the factor is the factor score, and the scores of all items are added to obtain the total score.

Countries

China

Contacts

Primary ContactJing Shi, Bachelor
1156769381@qq.com86-13774390145
Backup ContactQian Guo, M.D.
guoqian1205@vip.163.com86-13761005210

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026